A recent commentary in Nature Reviews Gastroenterology & Hepatology, written by Dr. Susan E. Erdman from the Division of Comparative Medicine at the Massachusetts Institute of Technology in Cambridge (USA), has covered the role of microbial strategies in cancer prevention and remission.

Digestive disorders, from gut discomfort to inflammatory bowel diseases (IBD) and cancer, are rising in many countries. Research and clinical studies on the interaction of gut microbiota and digestive health, are providing stimulating data. However, their connection is not fully understood and gut fungi have recently been suggested to play a role as well.